12:00 AM
 | 
Jul 22, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Zolpidem-containing medicines regulatory update

EMA's Pharmacovigilance Risk Assessment Committee (PRAC) began a review of zolpidem-containing medicines for short-term relief of insomnia following concerns that some patients may experience drowsiness and slower reactions the day after taking the drug. The review will consider whether lower doses of zolpidem could reduce the likelihood of reduced...

Read the full 225 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >